As of Mar 30
| -0.0209 / -3.79%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +843.22% increase from the last price of 0.53.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.